Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel B Salit

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Bone Marrow Transplantation|April 10, 2019
Pre-hematopoietic cell transplant Ruxolitinib in patients with primary and secondary myelofibrosisRachel B Salit, Bart L Scott, Emily A Stevens, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2020
Early Mixed Lymphoid Donor/Host Chimerism is Associated with Improved Transplant Outcome in Patients with Primary or Secondary MyelofibrosisH Joachim Deeg, Rachel B Salit, Tim Monahan, et al.
Transplantation and Cellular Therapy|September 15, 2025
Pre-Hematopoietic Cell Transplantation Ruxolitinib in Transplantation-Eligible Patients with Myelofibrosis: Long-Term Outcomes of a Phase II Prospective StudyRachel B Salit, Xinyi Fan, Ted A Gooley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 24, 2018
Quality of Life of Caregivers of Hematopoietic Cell Transplant RecipientsKareem Jamani, Lynn E Onstad, Merav Bar, et al.
Cancer|August 20, 2015
Resilience, health, and quality of life among long-term survivors of hematopoietic cell transplantationAbby R Rosenberg, Karen L Syrjala, Paul J Martin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 4, 2020
Return-to-Work Guidelines and Programs for Post-Hematopoietic Cell Transplantation Survivors: An Initial SurveyRachel B Salit, Stephanie J Lee, Linda J Burns, et al.
Blood Advances|July 25, 2020
Treosulfan-based conditioning is feasible and effective for cord blood recipients: a phase 2 multicenter studyFilippo Milano, Jonathan A Gutman, H Joachim Deeg, et al.
Transplantation and Cellular Therapy|October 2, 2022
American Society for Transplantation and Cellular Therapy Return to Work Guidance Committee Recommendations for Health Care Providers Who Take Care of Hematopoietic Cell Transplantation PatientsRachel B Salit, Katie Schoeppner, Chiara De Biase, et al.
Cancer|October 29, 2018
Post-transplantation employment status of adult survivors of childhood allogeneic hematopoietic cell transplant: A report from the Center for International Blood and Marrow Transplant Research (CIBMTR)Neel S Bhatt, Ruta Brazauskas, Heather R Tecca, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 1, 2018
Prognostic Performance of the Augmented Hematopoietic Cell Transplantation-Specific Comorbidity/Age Index in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation from Alternative Graft SourcesMahmoud Elsawy, Barry E Storer, Filippo Milano, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Bone Marrow Transplantation|April 10, 2019
Pre-hematopoietic cell transplant Ruxolitinib in patients with primary and secondary myelofibrosisRachel B Salit, Bart L Scott, Emily A Stevens, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2020
Early Mixed Lymphoid Donor/Host Chimerism is Associated with Improved Transplant Outcome in Patients with Primary or Secondary MyelofibrosisH Joachim Deeg, Rachel B Salit, Tim Monahan, et al.
Transplantation and Cellular Therapy|September 15, 2025
Pre-Hematopoietic Cell Transplantation Ruxolitinib in Transplantation-Eligible Patients with Myelofibrosis: Long-Term Outcomes of a Phase II Prospective StudyRachel B Salit, Xinyi Fan, Ted A Gooley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 24, 2018
Quality of Life of Caregivers of Hematopoietic Cell Transplant RecipientsKareem Jamani, Lynn E Onstad, Merav Bar, et al.
Cancer|August 20, 2015
Resilience, health, and quality of life among long-term survivors of hematopoietic cell transplantationAbby R Rosenberg, Karen L Syrjala, Paul J Martin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 4, 2020
Return-to-Work Guidelines and Programs for Post-Hematopoietic Cell Transplantation Survivors: An Initial SurveyRachel B Salit, Stephanie J Lee, Linda J Burns, et al.
Blood Advances|July 25, 2020
Treosulfan-based conditioning is feasible and effective for cord blood recipients: a phase 2 multicenter studyFilippo Milano, Jonathan A Gutman, H Joachim Deeg, et al.
Transplantation and Cellular Therapy|October 2, 2022
American Society for Transplantation and Cellular Therapy Return to Work Guidance Committee Recommendations for Health Care Providers Who Take Care of Hematopoietic Cell Transplantation PatientsRachel B Salit, Katie Schoeppner, Chiara De Biase, et al.
Cancer|October 29, 2018
Post-transplantation employment status of adult survivors of childhood allogeneic hematopoietic cell transplant: A report from the Center for International Blood and Marrow Transplant Research (CIBMTR)Neel S Bhatt, Ruta Brazauskas, Heather R Tecca, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 1, 2018
Prognostic Performance of the Augmented Hematopoietic Cell Transplantation-Specific Comorbidity/Age Index in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation from Alternative Graft SourcesMahmoud Elsawy, Barry E Storer, Filippo Milano, et al.
Pageof 5